Fig 2. MCP-3, HGF and CXCL9 as markers to discriminate between non-UC, inactive UC and active UC presented as Principal Component Analysis.
Serum samples were subjected to Olink’s Proseek® Multiplex Inflammation-I96×96 immunoassay. Sample size: non-UC n = 23; inactive UC (SCCAI<5) n = 36, active UC (SCCAI>5) n = 19. Significance was evaluated by using ordinal regression analysis.